Robert Attaran
Interventional Cardiology · Bridgeport, CTNPI 1629270616
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (32.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Medtronic at 59.0% of the total.
Across 46 payments — averaging $254.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Philips North America LLC$4K
- Cardiovascular Systems Inc.$508
- Hikma Pharmaceuticals USA$38
Across 68 payments — averaging $2816.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$109K
- Abbott$45K
- Intact Vascular, Inc.$17K
- Bard Peripheral Vascular, Inc.$13K
- Cook Research Incorporated$4K
- Boston Scientific$4K
What the payments were for
- Consulting fees$3,82333%
- Speaking & faculty fees$2,80024%
- Travel & lodging$3,30328%
- Food & beverage$1,73715%
- Gifts$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $6,901 |
| Philips North America LLC | 3 | $4,240 |
| Cardiovascular Systems Inc. | 8 | $508 |
| Hikma Pharmaceuticals USA | 2 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,687 in reported general payments places this provider in the 65th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 69 | $91,024 |
| XareltoRivaroxaban | 45 | $55,445 |
| Repatha SureclickEvolocumab | 44 | $39,008 |
| BrilintaTicagrelor | 24 | $24,538 |
| FarxigaDapagliflozin Propanediol | 21 | $21,993 |
| Praluent PenAlirocumab | 14 | $6,725 |
| Prasugrel Hcl | 22 | $2,036 |
| Rosuvastatin Calcium | 146 | $1,349 |
| Metoprolol Succinate | 103 | $1,125 |
| ClopidogrelClopidogrel Bisulfate | 87 | $971 |
| Atorvastatin Calcium | 124 | $919 |
| Ezetimibe | 52 | $772 |
| Losartan Potassium | 85 | $652 |
| Cilostazol | 20 | $541 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $461 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Bridgeport
- Kwasi DakwaBridgeport$3K
- Amit VoraNew Haven$409K
- Craig ThompsonHartford$222K
- Michael NannaNew Haven$60K
- Jawad HaiderBloomfield$44K
- Sameer NagpalNew Haven$43K
- Khagendra DahalFarmington$42K
- Abdul QaziHartford$38K
- Sarfaraz MemonHartford$30K
- Edward CarrerasStratford$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.